Your browser doesn't support javascript.
loading
Applicability of the SPAN-100 index in a prospective and contemporary cohort of patients treated with intravenous rtPA in Catalonia. / Aplicabilidad del índice SPAN-100 en una cohorte prospectiva y contemporánea de pacientes tratados con rtPA por vía intravenosa en Cataluña.
Abilleira, S; Ribera, A; Quesada, H; Rubiera, M; Castellanos, M; Vargas, M; Gomis, M; Krupinski, J; Delgado-Mederos, R; Gómez-Choco, M; Giralt-Steinhauer, E; Garcia, M C; Pellisé, A; Purroy, F; Garcés, M; Gallofré, M.
Afiliação
  • Abilleira S; Plan Director de Enfermedades Cerebrovasculares, Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), Barcelona, España. Electronic address: sabilleira@gencat.cat.
  • Ribera A; Unidad de Epidemiología Cardiovascular, Servicio de Cardiología, Hospital Vall d'Hebrón , Barcelona, España.
  • Quesada H; Servicio de Neurología, Hospital de Bellvitge, l'Hospitalet de Llobregat, Barcelona, España.
  • Rubiera M; Servicio de Neurología, Hospital Vall d'Hebrón, Barcelona, España.
  • Castellanos M; Servicio de Neurología, Hospital Josep Trueta, Girona, España.
  • Vargas M; Servicio de Neurología, Hospital Clínic, Barcelona, España.
  • Gomis M; Servicio de Neurología, Hospital Germans Trias, Badalona, España.
  • Krupinski J; Servicio de Neurología, Hospital Mútua de Terrassa, Terrassa, España.
  • Delgado-Mederos R; Servicio de Neurología, Hospital de Sant Pau, Barcelona, España.
  • Gómez-Choco M; Servicio de Neurología, Hospital Moisès Broggi, Sant Joan Despí, España.
  • Giralt-Steinhauer E; Servicio de Neurología, Hospital del Mar, Barcelona, España.
  • Garcia MC; Servicio de Neurología, Hospital Parc Taulí, Sabadell, España.
  • Pellisé A; Servicio de Neurología, Hospital Joan XXIII, Tarragona, España.
  • Purroy F; Servicio de Neurología, Hospital Arnau de Vilanova, Lleida, España.
  • Garcés M; Servicio de Neurología, Hospital Verge de la Cinta, Tortosa, España.
  • Gallofré M; Plan Director de Enfermedades Cerebrovasculares, Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS), Barcelona, España.
Neurologia ; 31(9): 592-598, 2016.
Article em En, Es | MEDLINE | ID: mdl-25542499
ABSTRACT

BACKGROUND:

Prognostic scales can be helpful for selecting patients for reperfusion treatment. This study aims to assess the prognostic ability of the recently published SPAN-100 index in a large cohort of stroke patients treated with intravenous thrombolysis (IV rtPA).

METHODS:

Using data from the prospective registery of all reperfusion treatments administered in Catalonia, we selected patients treated with IV rtPA alone between 2011 and 2012. The SPAN-100 index was calculated as the sum of age (years) and NIHSS score, and patients in the cohort were classified as SPAN-100 positive [≥ 100] or SPAN-100 negative [< 100]. We measured raw and adjusted rates of symptomatic intracerebral haemorrhage (SICH), mortality, and 3-month functional outcome (mRS 0-2) for each SPAN-100 category. Area under the ROC curve was calculated to predict the main outcome measures.

RESULTS:

We studied 1685 rtPA-treated patients, of whom 1405 (83%) were SPAN-100 negative. The SICH rates adjusted for sex, pre-stroke mRS, hypertension, diabetes, dyslipidaemia, ischaemic heart disease, heart failure, atrial fibrillation, prior TIA/stroke and time to thrombolysis did not differ between groups, but likelihood of functional independence (mRS 0-2) at 3 months was nearly 8 times higher in the SPAN-100 negative group than in the positive group. Furthermore, the 3-month mortality rate was 5 times higher in the SPAN-100 positive group. ROC curve analysis showed high specificities for predicting both functional independence and 3-month mortality for a cut-off point of 100.

CONCLUSION:

The SPAN-100 index is a simple and straightforward method that may be useful for selecting candidates for rtPA treatment in doubtful cases, and for informing patients and their relatives about likely outcomes.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Terapia Trombolítica / Avaliação de Resultados em Cuidados de Saúde / Ativador de Plasminogênio Tecidual / Acidente Vascular Cerebral / Fibrinolíticos Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male País/Região como assunto: Europa Idioma: En / Es Revista: Neurologia Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Terapia Trombolítica / Avaliação de Resultados em Cuidados de Saúde / Ativador de Plasminogênio Tecidual / Acidente Vascular Cerebral / Fibrinolíticos Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male País/Região como assunto: Europa Idioma: En / Es Revista: Neurologia Ano de publicação: 2016 Tipo de documento: Article